# Cryoablation with or Without Serplulimab in Treating Patients with Stage I-IIA Non-small Cell Lung Cancer

> **NCT06580665** · NA · NOT_YET_RECRUITING · sponsor: **Shanghai Chest Hospital** · enrollment: 134 (estimated)

## Conditions studied

- Non-small Cell Lung Cancer

## Interventions

- **PROCEDURE:** Cryoablation
- **DRUG:** Serplulimab

## Key facts

- **NCT ID:** NCT06580665
- **Lead sponsor:** Shanghai Chest Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-09-01
- **Primary completion:** 2028-09-01
- **Final completion:** 2030-08-11
- **Target enrollment:** 134 (ESTIMATED)
- **Last updated:** 2024-08-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06580665

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06580665, "Cryoablation with or Without Serplulimab in Treating Patients with Stage I-IIA Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06580665. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*